4[1]Jamieson ER,Lippard SJ.Structure,recognition,and processing of cisplatin-DNA adducts[J].Chem Rev,1999,99(9):2467-2498.
5[2]Galanski M,Jakupec MA,Keppler BK.Update of the preclinical situation of anticancer platinum complexes:novel design strategies and innovative analytical approaches[J].Curr Med Chem,2005,12(18):2075-2094.
6[4]Sternburg CN,De mulder P,Fossa S,et al.Lobaplatin in advanced urothelial tract tumors.the genitourinary group of the european organization for research and treatment of cancer (EORTC)[J].Ann Oncol.1997,8(7):695-696.
9Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 2007, 13:4429-4434.
10Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy : updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol, 2008, 26:778-785.
